• https://www.facebook.com/fcadcom
  • http://www.twitter.com/fcadgroup
  • http://www.linkedin.com/company/fcad-group
  • https://vk.com/fcadgroup
  • https://t.me/fcadcom
  • http://fcadgroup.tumblr.com/
  • https://www.youtube.com/fcadgroup
  • https://www.caming.com/feed/
Please change screen to horizontal for better experience if you are checking Caming on your mobile phone. Email us by [email protected] or visit our sales website www.watson-Int.com
Caming Pharmaceutical Ltd - Focusing on development of pharmaceutical-related chemicals
  • About Caming
  • Key Products
  • Pharmaceutical Chemicals
    • APIs
    • Intermediates
    • Steroid Hormones
    • Impurities
    • Excipients
    • Others
  • Animal Health
  • Diagnostic Reagents
  • R&D
  • Contact Us
  • Visit FCAD

Tag Archives: «Travoprost»

0
(+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE CAS 53872-60-9

(+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE CAS 53872-60-9

In Intermediates, Pharmaceutical Chemicals, Products

53872-60-9,(+)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-[(1E,3R)-3-HYDROXY-4-(3-TRIFLUOROMETHYL)PHENOXY-1-BUTENYL]-2H-CYCLOPENTA[B]FURAN-2-ONE,Travoprost

0
(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one CAS 208111-98-2

(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one CAS 208111-98-2

In Intermediates, Pharmaceutical Chemicals, Products

208111-98-2,(3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one,Travoprost

0
[1,1′-Biphenyl]-4-carboxylicacid(3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-ylester CAS 54142-64-2

[1,1′-Biphenyl]-4-carboxylicacid(3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-ylester CAS 54142-64-2

In Intermediates, Pharmaceutical Chemicals, Products

54142-64-2,[1,1′-Biphenyl]-4-carboxylicacid(3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-ylester,Travoprost

0
[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-ylester CAS 114488-91-4

[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-ylester CAS 114488-91-4

In Intermediates, Pharmaceutical Chemicals, Products

114488-91-4,[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-ylester,Travoprost

0
[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-4-[(1E,3R)-3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-(trifluoroMethyl)phenoxy]-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-ylester CAS 865087-08-7

[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-4-[(1E,3R)-3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-(trifluoroMethyl)phenoxy]-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-ylester CAS 865087-08-7

In Intermediates, Pharmaceutical Chemicals, Products

865087-08-7,[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-4-[(1E,3R)-3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-(trifluoroMethyl)phenoxy]-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-ylester,Travoprost

0
2H-Cyclopenta[b]furan-2,5-diol,hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-,(3aR,4R,5R,6aS)- CAS 1204185-88-5

2H-Cyclopenta[b]furan-2,5-diol,hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-,(3aR,4R,5R,6aS)- CAS 1204185-88-5

In Intermediates, Pharmaceutical Chemicals, Products

1204185-88-5,2H-Cyclopenta[b]furan-2,5-diol,hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-,(3aR,4R,5R,6aS)-,Travoprost

0
Dimethyl[2-oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonate CAS 54094-19-8

Dimethyl[2-oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonate CAS 54094-19-8

In Intermediates, Pharmaceutical Chemicals, Products

54094-19-8,Dimethyl[2-oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonate,Travoprost

0
[1,1′-Biphenyl]-4-carboxylicacid(3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-ylester CAS 54142-64-2

[1,1′-Biphenyl]-4-carboxylicacid(3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-ylester CAS 54142-64-2

In Intermediates, Pharmaceutical Chemicals, Products

54142-64-2,[1,1′-Biphenyl]-4-carboxylicacid(3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-ylester,Travoprost

0
[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-ylester CAS 114488-91-4

[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-ylester CAS 114488-91-4

In Intermediates, Pharmaceutical Chemicals, Products

114488-91-4,[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2-oxo-2H-cyclopenta[b]furan-5-ylester,Travoprost

0
[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-4-[(1E,3R)-3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-(trifluoroMethyl)phenoxy]-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-ylester CAS 865087-08-7

[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-4-[(1E,3R)-3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-(trifluoroMethyl)phenoxy]-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-ylester CAS 865087-08-7

In Intermediates, Pharmaceutical Chemicals, Products

865087-08-7,[1,1′-Biphenyl]-4-carboxylicacid,(3aR,4R,5R,6aS)-4-[(1E,3R)-3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-(trifluoroMethyl)phenoxy]-1-butenyl]hexahydro-2-oxo-2H-cyclopenta[b]furan-5-ylester,Travoprost

  • 1
  • 2
  • 3
  • >

New Products

  • R-HPBA CAS 29678-81-7
  • L-HPE CAS 90891-21-7
  • L-HPA CAS 943-73-7
  • BDO CAS 130792-45-9
  • R-HPBE CAS 90315-82-5

RSS FCAD News

  • FCAD Develops Two Derivatives of R-Lipoic Acid to Solve Chemical Instability Issues

Pop Categories

Anastrozole Apixaban Calcium Folinate Leucovorin Calcium Canagliflozin Corey-lactone D-cloprostenol Dabigatran Dinoprost,Dinoprostone,Alprostadil Duloxetine Efinaconazole Eldecalcitol Entecavir Erlotinib Ezetimibe Febuxostat Gefitinib ILOPROST Imiquimod Latanoprost,Bimatoprost Lesinurad Limaprost,Gemeprost Lubiprostone Lumacaftor Neratinib Nilotinib Palbociclib Piperidine Pitavastatin Calcium Posaconazole Prostaglandin Prostaglandin synthesis;Corey lactone derivatives Prostaglandin synthesis;Two-component coupling Pyridine Rivaroxaban Rosuvastatin Sofosbuvir Tadalafil Tafluprost Three-component coupling Ticagrelor Travoprost Treprostinil Two-component-coupling Vemurafenib Voglibose
Copyright © 2019 Caming Pharmaceutical Ltd - Committed to APIs, Intermediates, Impurities, Veterinary Products & Diagnostic Reagents | A FCAD Company